The Latest in Billing & Reimbursement from Ronda Buhrmester: Oxygen Equipment Updates and Reminders

Published in Member Communities on June 04, 2025

Ronda BuhrmesterBy Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, VGM & Associates 

Oxygen Equipment Groups 

Within the oxygen equipment policy (LCD), oxygen coverage is grouped into three different categories. To determine which category the patient could potentially get coverage for oxygen equipment all starts with the test results. Once the test results are known that will then determine the specific group, the additional coverage criteria will need to be met. 

The main category is Group I where the oxygen testing being conducted would show the patient qualify with a pulse oximetry at 88% or less. Group II is the group where oxygen saturations would result at precisely 89% and additional coverage criteria. 

Group III is the newer group within the policy where the oxygen testing results would be normal. The oxygen saturation would not show hypoxemia. The additional coverage criteria for this group as outlined in the policy is, “A medical condition with distinct physiologic, cognitive, and/or functional symptoms documented in high-quality, peer-reviewed literature to be improved by oxygen therapy, such as cluster headaches (not all inclusive).” 

This group mainly refers to cluster headaches because this was the reason the oxygen policy was updated in January 2023, and the condition of cluster headaches went through a clinical trial period. 

Now is the time to review claims for oxygen equipment because these continue to be included in reviews and audits. Any supplier with CGS Medicare that are in jurisdictions B and C who have provided oxygen for Group III could receive an audit. When pulling reports from the billing software, this can be done by looking for the modifier N3. Remember the modifiers are N1 for Group I, N2 for Group II, and N3 for Group III.  

A recent article states that suppliers were using the modifier N3 more than expected related to HCPCS E1390. This is really concerning for suppliers billing for oxygen claims. Because of the results found by the CERT contractor, CGS DME MAC will be performing a widespread pre-payment audit.  

Don’t be surprised if there is a post-payment audit performed by another CMS contractor on the N3 modifier being overused with the E1390 HCPCS code. 

For any questions regarding oxygen equipment coverage or audits, please reach out to me via email at ronda.buhrmester@vgm.com or by calling 217-493-5440. 


TAGS

  1. billing & reimbursement
  2. oxygen
  3. reimbursement

From Our Experts

Customization, Communication, and Clinical Strength: The Indie Edge in Complex Rehab thumbnail Customization, Communication, and Clinical Strength: The Indie Edge in Complex Rehab Independent complex rehab providers say they are differentiating themselves with product customization and referral and patient engagement. The Rising Cost of Doing Business in the Mobility and Complex Rehab Technology Industry thumbnail The Rising Cost of Doing Business in the Mobility and Complex Rehab Technology Industry This article delves into concerns of rising costs in the mobility and complex rehab technology (CRT) industry and explores potential strategies to mitigate their impact. Empowering Patients and Caregivers: Advocacy and Education thumbnail Empowering Patients and Caregivers: Advocacy and Education Whether it's a safety bed, mobility aid, or a respiratory device, healthcare providers' roles extend beyond equipment delivery—we are educators, advocates, and allies. Staffing Ratios and Compensation Insights for U.S. Rehab Members and CRT Dealers thumbnail Staffing Ratios and Compensation Insights for U.S. Rehab Members and CRT Dealers This report provides insights into team structures and pay for key roles like ATPs, service technicians, and billing personnel. Marketing: Embrace the Happy Customer thumbnail Marketing: Embrace the Happy Customer In today's hyper-connected world, customer satisfaction isn't just a metric—it's a marketing engine. A Letter From the President: July 2025 thumbnail A Letter From the President: July 2025 From evolving reimbursement models to the complexities of competitive bidding, the landscape continues to shift beneath our feet, but VGM is here for you. How the June 2025 MedPAC Report Shapes the Future of HME thumbnail How the June 2025 MedPAC Report Shapes the Future of HME The June 2025 Report to Congress from the Medicare Payment Advisory Commission (MedPAC) offers critical insights into the evolving landscape of Medicare services. While the report does not focus exclusively on home medical equipment (HME) or durable medical equipment (DME), several areas touch on themes that are highly relevant to the industry's future—particularly around home health care, Medicare Advantage (MA), and supplemental benefits. Navigating the New CMS Landscape with the HMV and RAD Decision Memo for COPD thumbnail Navigating the New CMS Landscape with the HMV and RAD Decision Memo for COPD Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, shares insights on the newly finalized National Coverage Determination (NCD) for home mechanical ventilation (HMV) and respiratory assist devices (RAD).